TEST BANK NURS 6630 MIDTERM
EXAM QUESTIONS AND ANSWERS
GRADED A+ 2025/2026
Patient refusal to follow prescribed treatment. - ANS Noncompliance
Disruption in brain chemical levels affecting mood. - ANS Neurotransmitter Imbalance
Symptoms that add to the patient's experience. - ANS Positive Symptoms
Increased restlessness or anxiety in schizophrenia. - ANS Agitation
Neurotransmitter linked to mood regulation. - ANS Serotonin
First antidepressant targeting serotonin imbalance. - ANS Prozac
Impaired neurotransmitter functions in psychiatric illnesses. - ANS Dysfunctioning
Neurotransmitter Systems
Process of converting genetic information into proteins. - ANS Gene Expression
Protein that initiates gene transcription. - ANS Transcription Factor
1 @COPYRIGHT 2025/2026 ALLRIGHTS RESERVED.
,Changes in behavior influencing genetic expression. - ANS Behavior Modification
Enzyme system affecting drug metabolism. - ANS Cytochrome P450
Amount of drug available after metabolism. - ANS Bioavailability
Study of drug absorption, distribution, metabolism, and excretion. - ANS Pharmacokinetics
Some Asians require reduced doses of medications. - ANS Lower Drug Doses
Receptors that mediate cellular responses to neurotransmitters. - ANS G-Protein Linked
Receptors
Medications that block receptor activity. - ANS Antagonistic Traits
Medication used for treatment-resistant schizophrenia. - ANS Clozapine (Clozaril)
Smoking can alter medication metabolism. - ANS Smoking Impact
Mood stabilizer associated with thrombocytopenia. - ANS Carbamazepine (Tegretol)
Medication used to treat mood disorders. - ANS Mood Stabilizer
Antidepressant also used for chronic pain. - ANS Amitriptyline (Elavil)
SSRI antidepressant for depression and anxiety. - ANS Fluoxetine (Prozac)
2 @COPYRIGHT 2025/2026 ALLRIGHTS RESERVED.
,Low platelet count caused by medication. - ANS Drug-Induced Thrombocytopenia
An antidepressant used for mood disorders. - ANS Amitriptyline (Elavil)
Decreases serotonin and dopamine activity. - ANS Inverse agonist
Medications for anxiety and panic disorders. - ANS Benzodiazepines
Receptors that mediate rapid synaptic transmission. - ANS Ionotropic receptors
Medication used for smoking cessation. - ANS Varenicline (Chantix)
Drugs that partially stimulate receptors. - ANS Partial agonists
Medications used to stabilize mood and treat seizures. - ANS Anticonvulsants
Channels activated by neurotransmitter binding. - ANS Ligand-gated ion channels
An SSRI used to treat panic disorder. - ANS Sertraline
Used temporarily to manage anxiety symptoms. - ANS Short-acting benzodiazepine
Medications that prevent mood swings in bipolar disorder. - ANS Mood stabilizers
Antidepressants with significant food interactions. - ANS MAO inhibitors
An SSRI with uncommon sedation side effects. - ANS Fluoxetine
3 @COPYRIGHT 2025/2026 ALLRIGHTS RESERVED.
, Signs of elevated mood and hyperactivity. - ANS Manic symptoms
Dopamine receptors targeted by antipsychotics. - ANS D2 receptors
Involuntary movements from long-term antipsychotic use. - ANS Tardive dyskinesia
Severe increase in blood pressure from food interactions. - ANS Hypertensive crisis
Receptors involved in serotonin signaling. - ANS Serotonin 3 receptors
Cholinergic receptors that respond to acetylcholine. - ANS Nicotinic receptors
Receptors activated by the neurotransmitter acetylcholine. - ANS Cholinergic receptors
Inhibitory receptors in the central nervous system. - ANS Glycine receptors
Stimulates dopamine receptors to treat Parkinson's disease. - ANS Dopamine agonist
Primary binding site for dopamine agonists. - ANS D2 Receptors
Pathways influencing cognitive symptoms in schizophrenia. - ANS Mesocorticol Projections
Antidepressant with rare induction of mania. - ANS Fluoxetine
Medications requiring avoidance of certain decongestants. - ANS MAO Inhibitors
Severe increase in blood pressure from drug interactions. - ANS Hypertensive Crisis
4 @COPYRIGHT 2025/2026 ALLRIGHTS RESERVED.
EXAM QUESTIONS AND ANSWERS
GRADED A+ 2025/2026
Patient refusal to follow prescribed treatment. - ANS Noncompliance
Disruption in brain chemical levels affecting mood. - ANS Neurotransmitter Imbalance
Symptoms that add to the patient's experience. - ANS Positive Symptoms
Increased restlessness or anxiety in schizophrenia. - ANS Agitation
Neurotransmitter linked to mood regulation. - ANS Serotonin
First antidepressant targeting serotonin imbalance. - ANS Prozac
Impaired neurotransmitter functions in psychiatric illnesses. - ANS Dysfunctioning
Neurotransmitter Systems
Process of converting genetic information into proteins. - ANS Gene Expression
Protein that initiates gene transcription. - ANS Transcription Factor
1 @COPYRIGHT 2025/2026 ALLRIGHTS RESERVED.
,Changes in behavior influencing genetic expression. - ANS Behavior Modification
Enzyme system affecting drug metabolism. - ANS Cytochrome P450
Amount of drug available after metabolism. - ANS Bioavailability
Study of drug absorption, distribution, metabolism, and excretion. - ANS Pharmacokinetics
Some Asians require reduced doses of medications. - ANS Lower Drug Doses
Receptors that mediate cellular responses to neurotransmitters. - ANS G-Protein Linked
Receptors
Medications that block receptor activity. - ANS Antagonistic Traits
Medication used for treatment-resistant schizophrenia. - ANS Clozapine (Clozaril)
Smoking can alter medication metabolism. - ANS Smoking Impact
Mood stabilizer associated with thrombocytopenia. - ANS Carbamazepine (Tegretol)
Medication used to treat mood disorders. - ANS Mood Stabilizer
Antidepressant also used for chronic pain. - ANS Amitriptyline (Elavil)
SSRI antidepressant for depression and anxiety. - ANS Fluoxetine (Prozac)
2 @COPYRIGHT 2025/2026 ALLRIGHTS RESERVED.
,Low platelet count caused by medication. - ANS Drug-Induced Thrombocytopenia
An antidepressant used for mood disorders. - ANS Amitriptyline (Elavil)
Decreases serotonin and dopamine activity. - ANS Inverse agonist
Medications for anxiety and panic disorders. - ANS Benzodiazepines
Receptors that mediate rapid synaptic transmission. - ANS Ionotropic receptors
Medication used for smoking cessation. - ANS Varenicline (Chantix)
Drugs that partially stimulate receptors. - ANS Partial agonists
Medications used to stabilize mood and treat seizures. - ANS Anticonvulsants
Channels activated by neurotransmitter binding. - ANS Ligand-gated ion channels
An SSRI used to treat panic disorder. - ANS Sertraline
Used temporarily to manage anxiety symptoms. - ANS Short-acting benzodiazepine
Medications that prevent mood swings in bipolar disorder. - ANS Mood stabilizers
Antidepressants with significant food interactions. - ANS MAO inhibitors
An SSRI with uncommon sedation side effects. - ANS Fluoxetine
3 @COPYRIGHT 2025/2026 ALLRIGHTS RESERVED.
, Signs of elevated mood and hyperactivity. - ANS Manic symptoms
Dopamine receptors targeted by antipsychotics. - ANS D2 receptors
Involuntary movements from long-term antipsychotic use. - ANS Tardive dyskinesia
Severe increase in blood pressure from food interactions. - ANS Hypertensive crisis
Receptors involved in serotonin signaling. - ANS Serotonin 3 receptors
Cholinergic receptors that respond to acetylcholine. - ANS Nicotinic receptors
Receptors activated by the neurotransmitter acetylcholine. - ANS Cholinergic receptors
Inhibitory receptors in the central nervous system. - ANS Glycine receptors
Stimulates dopamine receptors to treat Parkinson's disease. - ANS Dopamine agonist
Primary binding site for dopamine agonists. - ANS D2 Receptors
Pathways influencing cognitive symptoms in schizophrenia. - ANS Mesocorticol Projections
Antidepressant with rare induction of mania. - ANS Fluoxetine
Medications requiring avoidance of certain decongestants. - ANS MAO Inhibitors
Severe increase in blood pressure from drug interactions. - ANS Hypertensive Crisis
4 @COPYRIGHT 2025/2026 ALLRIGHTS RESERVED.
